Eli Lilly is a 'play' in type 2 diabetes and obesity: Sam Waksal
Graviton Biopharmaceuticals Holdings CEO Sam Waksal argues that there will be 'great growth' in the pharmaceutical industry.
Dr. Greg Murphy: Dr. Fauci and the CDC's COVID response hurt patients' trust in doctors
North Carolina Rep. Dr. Greg Murphy explains why he believes the coronavirus leaked from gain-of-function research in a Wuhan lab on 'The Evening Edit.'
Rep. Guy Reschenthaler: EcoHealth Alliance can't be trusted with this money
Rep. Guy Reschenthaler, R-Penn., on the spending cuts debt showdown in Congress, the House passing the 'Strategic Production Response Act' and the his push to defund EcoHealth Alliance.
Drug-shipping giant AmerisourceBergen gets 'fresh, bold' new name in Cencora
AmerisourceBergen chairman and CEO Steven Collis explains why the drug wholesale company is changing its name to Cencora on 'The Claman Countdown.'
What really happened in China's Wuhan lab?
UC Berkeley physics professor Richard Muller and Fox News contributor Tammy Bruce break down research into the COVID-19's origins on 'The Evening Edit.'
COVID vaccine mandates hurt the doctor-patient relationship: Dr. Frank Contacessa
MDVIP internist Dr. Frank Contacessa reacts to Gov. DeSantis moving to permanently ban COVID mandates in Florida on 'Varney & Co.'
Ozempic shortage a 'serious problem' for diabetics: Dr. Bob Lahita
St. Joseph Health Institute director Dr. Bob Lahita discusses how the Ozempic craze is causing issues for diabetics and addresses the rise in medical costs on 'Varney & Co.'
Wilbur Ross talks new investment
Former Secretary of Commerce Wilbur Ross announced a business combination agreement between Aprinoia Therapeutics and Ross Acquisition Corp to create a publicly listed company focused on neurodegenerative diseases.
Energy transition has 'not gone well': Steve Pagliuca
Bain Capital senior advisor and Boston Celtics co-owner Steve Pagliuca on his new role at Bain Capital, his market outlook, biotech, gene editing and investing in green energy.
Scientists reverse the aging process in mice, are humans next?
Dr. Marty Makary discusses new research that shows scientists have made inroads into reversing the aging process on 'Varney & Co.'
Pharmaceutical industry lobbied to shape COVID vaccine content
Rep. Darrell Issa, R-Calif., discusses Biden's classified documents debacle, the latest 'Twitter File' that highlights the pharmaceutical industry's role in vaccine content, the U.S. debt ceiling and China's economy.
L’Oreal reveals world’s first handheld makeup applicator for people with limited hand, arm mobility
L’Oréal announced that Lancome will pilot the world’s first handheld lipstick applicator, with smart motion technology designed for people with limited hand and arm mobility.
Moderna CEO talks company transformation: 'This wasn’t going to be a one drug company'
Moderna CEO Stephane Bancel joins 'Mornings with Maria' to discuss how it transformed during the pandemic and its lawsuit against Pfizer.
Alphabet unit Verily to trim more than 200 jobs
Verily Life Sciences, formerly Google Life Sciences, a health care company and one of the largest under Google parent Alphabet's, umbrella, will lay off 15%.
COVID moving into an endemic setting: Moderna CEO Stephane Bancel
Moderna CEO Stephane Bancel discusses the end stages of the COVID pandemic, booster shots, the company's outlook for 2023, RSV vaccines, the melanoma trials and mRNA technology.
Dr. Fauci responds to Elon Musk teasing 'Twitter File' release
DPCM Capital Chairman Emil Michael discusses the 'Fauci Files' ahead of its release, Elon Musk's 'end goal' for Twitter and a judge blocking pay increases for Uber drivers.
Cotons AI smart collar for dogs aims to provide real time health data: CES 2023
The South Korea-based company said that the gadget can monitor a dog's temperature, heart rate, and more.
Parents struggle to find medicine for their children
FOX Business correspondent Lydia Hu has the latest on the antibiotic shortage on 'Varney & Co.'
Newest COVID variant is like a 'seasonal flu' Americans will experience 'year on year': Dr. Kevin Campbell
Cardiologist Dr. Kevin Campbell predicts a spike in COVID-19 cases, though a low number of hospitalizations and deaths, for the latest omicron variant.
Dr. Frank Contacessa on combatting illness surge: ‘Take stock of what’s most important’
Northwell Health Internist Dr. Frank Contacessa breaks down the impact the winter season is having on the surge of illnesses spreading across the U.S. on ‘Cavuto: Coast to Coast.’



















